View source for Resource:B42f9886-0ca3-437f-99fe-4fd4c60b6c3e

{{Resource
|Resource Type=Cases
|Title=Premature release of clinical trials data
|Is About=This blog post describes a controversy that involved an industrial partner eager to report the results of an ongoing clinical trial based on analysing the first 25% of data.
|Important Because=It shows that academic and industrial research partners might have different priorities that do not always match.
|Important For=researchers; industry stakeholders
}}
{{Link
|Has Link=https://blogs.sciencemag.org/pipeline/archives/2015/05/13/how_not_to_handle_your_clinical_data
}}
{{Related To
|Related To Theme=Theme:Dc1ed216-1d37-49a9-9725-2b34e90b3ede
}}
{{Tags
|Involves=Orexigen; Steve Nissen
|Has Timepoint=2015
|Has Location=Cleveland Clinic; United States
|Has Virtue And Value=Reliability
|Has Good Practice And Misconduct=Publication Ethics; Premature data release
|Related To Research Area=LS 04.07 - Cardiovascular diseases
}}